Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
2009 NOV 23 ... the association in other populations, including any interrelationship with serum prostate-specific antigen. (Cancer Epidemiol Biomarkers Prev 2009;18(10):2643-9)." Weinstein and ...
2009 NOV 23 ... in the LNCaP human prostate carcinoma cell line and prostate adenocarcinomas of SV40T antigen transgenic rats by the Bowman-Birk inhibitor.' "The soybean-derived serine protease ...
2009 NOV 23 ... to recent research published in the journal Acta Radiologica, "In recent years, prostate-specific antigen (PSA) screening has been widely performed. As a result, patients who need to undergo a ...
2009 NOV 23 ... of Medicine and the University of Wisconsin-Madison have discovered that some elevated prostate-specific antigen (PSA) levels in men may be caused by a hormone normally occurring in the body, and are ...
Subject: Wake Forest University Baptist Medical Center
2009 NOV 23 ... of prostate cancer needs a biopsy of the prostate. Suspecting cancer from an increase in prostate-specific antigen (PSA) has a high negative rate at an initial prostate biopsy." "Cases ...
2009 NOV 23 ... occur for an immune response to be generated is the interaction between gp96 and the antigen presenting cell (APC) surface receptors (CD91, SR-A, TLR-2, and TLR-4). Our previous ...
2009 NOV 23 ... mice were injected intratibially with C4-2B CaP cells and treated with HE3235. Serum prostate-specific antigen (PSA) levels, tumor volume, immunohistochemistry, gene expression, and levels of ...
2009 NOV 23 ... New investigation results, 'A review of prostate-specific antigen screening prevalence and risk perceptions for first-degree relatives of men with ...
2009 NOV 23 ... Fresh data on prostate cancer are presented in the report 'Prostate-specific antigen velocity (PSAV): a practical role for PSA.' According to recent research from Port ...
2009 NOV 23 ... cancer (PCa) and those with ''no evidence of malignancy'' using ''benign'' prostate-specific antigen (bPSA) and the new automated Access benign prostatic hyperplasia-associated (BPHA) ...
2009 NOV 23 ... New Mayo Clinic research studied the association between prostate-specific antigen (PSA) levels and prostate size and found that routine annual evaluation of prostate ...
2009 NOV 23 ... research from the United States, "Although there is uncertainty about the effect of prostate-specific antigen (PSA) screening on the rate of prostate cancer death, there is little uncertainty about ...
2009 NOV 23 ... currently in Phase 3 clinical trials and the compound has demonstrated reduction in prostate-specific antigen (PSA) levels. Notably, TOK-001 is the first investigational new drug that decreases ...
